| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -6.1e-05 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -2.5e-05 | 1 |